Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben Benjamin

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Hematology (Amsterdam, Netherlands)|February 6, 2010
Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disordersMd Serajul Islam, Parameswaran Anoop, Phil Rice, et al.
The Journal of Gene Medicine|November 17, 2005
Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine modelChara A Kyriakou, Kwee L Yong, Reuben Benjamin, et al.
Frontiers in Immunology|February 28, 2022
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-StimulationLeena Halim, Kushal K Das, Daniel Larcombe-Young, et al.
Blood|October 19, 2006
Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft modelReuben Benjamin, Asim Khwaja, Nalini Singh, et al.
Frontiers in Oncology|March 16, 2026
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challengesAnas Ibraheem, Helena Vincentelli, Andrea Kuhnl, et al.
Hemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.
The Journal of Gene Medicine|January 29, 2008
Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antiseraRobert C Carlisle, Reuben Benjamin, Simon S Briggs, et al.
British Journal of Haematology|February 18, 2017
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experienceNicola Maciocia, Andrew Melville, Simon Cheesman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemiaJulio Delgado, Srinivas Pillai, Reuben Benjamin, et al.
BMJ Neurology Open|March 8, 2021
Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicityElisaveta Sokolov, Philipp Karschnia, Reuben Benjamin, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Hematology (Amsterdam, Netherlands)|February 6, 2010
Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disordersMd Serajul Islam, Parameswaran Anoop, Phil Rice, et al.
The Journal of Gene Medicine|November 17, 2005
Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine modelChara A Kyriakou, Kwee L Yong, Reuben Benjamin, et al.
Frontiers in Immunology|February 28, 2022
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-StimulationLeena Halim, Kushal K Das, Daniel Larcombe-Young, et al.
Blood|October 19, 2006
Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft modelReuben Benjamin, Asim Khwaja, Nalini Singh, et al.
Frontiers in Oncology|March 16, 2026
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challengesAnas Ibraheem, Helena Vincentelli, Andrea Kuhnl, et al.
Hemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.
The Journal of Gene Medicine|January 29, 2008
Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antiseraRobert C Carlisle, Reuben Benjamin, Simon S Briggs, et al.
British Journal of Haematology|February 18, 2017
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experienceNicola Maciocia, Andrew Melville, Simon Cheesman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemiaJulio Delgado, Srinivas Pillai, Reuben Benjamin, et al.
BMJ Neurology Open|March 8, 2021
Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicityElisaveta Sokolov, Philipp Karschnia, Reuben Benjamin, et al.
Pageof 5